Cancer Surgery Physician Referral Guide - Department of Surgery

Cancer 

Surgery 

Physician 

Referral 

Guide

Clinical Programs 

Cancer Surgery 

AT THE UNIVERSITY OF ARIZONA 

DEPARTMENT OF SURGERY 

Surgery and the perioperative care of patients are crucial 

components of many cancer treatments. At the University 

of Arizona Department of Surgery, our surgeons are 

nationally recognized for their outstanding surgical 

skills and exceptional patient care. The department is at 

the forefront of the latest surgical advances, including 

minimally invasive, laparoscopic, and robotic-assisted 

procedures. We offer the highest degree of specialization 

and experience in the surgical treatment of cancer, 

including state-of-the-art diagnostic techniques. 

The department is affiliated with University Medical 

Center and the Arizona Cancer Center, one of only 

a few institutions in the country to be designated a 

Comprehensive Cancer Center by the National Cancer 

Institute. Within a multidisciplinary framework, we 

extensively discuss and carefully develop individualized 

cancer treatment plans that draw on innovative surgical, 

medical, and radiation treatment protocols. In addition, 

qualified patients can enroll in clinical trials to assess 

promising new cancer treatment regimens. 

We work very closely with referring physicians, 

partnering with them to integrate surgical and nonsurgical 

therapies and to provide the most comprehensive 

inpatient and outpatient clinical services. 

Our focus is not only on finding a cure, but also on 

preserving the best quality of life. 

– Rainer W.G. Gruessner, MD 

Chairman, UA Department of Surgery 

– 2 – 

LIVER, PANCREAS, AND BILE DUCT CANCER 

5 Dr. Rainer Gruessner 

6 Dr. Hugo Villar 

10 Dr. Evan Ong 

9 Dr. Tun Jie 

7 Dr. Carlos Galvani 

COLON, RECTAL, AND ANAL CANCER 

10 Dr. V. Liana Tsikitis 

6 Dr. Alfred Cohen 


ESOPHAGEAL AND STOMACH CANCER 


10 Dr. Evan Ong 

7 Dr. Carlos Galvani 

12 Dr. Jonathan Daniel (Esophageal Cancer) 

BREAST CANCER 

9 Dr. Julie Lang 

11 Dr. Amy Waer 

8 Dr. Craig Hurst (Reconstructive Surgery) 

ENDOCRINE CANCER – 

THYROID, PARATHYROID, ADRENAL 

7 Dr. Marlon Guerrero 


SKIN AND SOFT TISSUE CANCER – 

MELANOMA, CARCINOMA, SARCOMA 

11 Dr. James Warneke 

10 Dr. Evan Ong (Isolated Limb Perfusion for Melanoma, 

Abdominal Metastatic Disease) 

8 Dr. Craig Hurst (Reconstructive Surgery) 

LUNG CANCER AND TUMORS OF THE 

CHEST WALL AND MEDIASTINUM 

12 Dr. Jonathan Daniel 

UROLOGIC CANCER 

13 Dr. Mitchell Sokoloff 

14 Dr. Matthew Gretzer 

14 Dr. Jonathan Walker 

15 Dr. Mike Nguyen 

BRAIN AND SKULL-BASE CANCER 

16 Dr. G. Michael Lemole, Jr. 

SINONASAL AND SKULL-BASE CANCER 

17 Dr. Alexander Chiu 

Referral Guide 

For a map 

and listing 

of Practice 

Locations, 

see page 

18.

DIVISION OF Surgical Oncology & 

HepatoPancreaticoBiliary 

Center 

Rainer Gruessner, MD, FACS, FICS 

Chairman, UA Department of Surgery 

Director, HepatoPancreaticoBiliary Center 

Chief, Division of Abdominal Transplantation 

Professor of Surgery and Immunology 

Specialties: Liver, Pancreas, and Bile Duct Cancer 

Our Surgeons 

Rainer Gruessner, MD, an internationally noted general surgeon 

and transplant surgeon as well as department chairman, also directs 

the HepatoPancreaticoBiliary Center and the Division of Abdominal 

New Patient Referrals: (520) 626-6793 

Private Office: (520) 626-4409 

Email: rgruessner@surgery.arizona.edu 

– 4 – – 5 – 

Transplantation. Before 

coming to the UA in July 

2007, he was professor 

of general and transplant 

surgery and vice chair of 

the Department of Surgery at the University of Minnesota. Previously, 

he served as professor and head of the Department of General and 

Transplant Surgery at the University Hospital in Zurich, Switzerland. 

In addition to his accomplishments in the field of transplantation, 

Dr. Gruessner has a major clinical interest in the surgical treatment 

of patients with malignant or benign tumors of the pancreas, liver, 

and bile ducts. He performs complex and extended resections for 

patients with advanced pancreatic, liver, and bile duct cancer. Selected 

patients with liver or bile duct cancer (irrespective of whether they 

underwent previous surgery) may also be candidates for a transplant. 

Dr. Gruessner’s research focus is on detecting tumor antigens and 

monitoring circulatory tumor cells. 

The HepatoPancreaticoBiliary Center is staffed by some of 

the most experienced and respected medical professionals in 

the nation, including surgical and medical oncologists as well as 

gastroenterologists, hepatologists, radiation oncologists, pathologists, 

and anesthesiologists. It is a unique resource for referring physicians 

and patients who require comprehensive, state-of-the-art care. 

(For more information, visit www.surgery.arizona.edu/hpb.) 

Dr. Gruessner has written 2 textbooks, more than 50 book chapters, 

and more than 300 published articles. A member of more than 15 

national and international societies, he serves on numerous societal 

and professional committees.

Hugo Villar, MD, FACS 

Chief, Division of Surgical Oncology 

Vice Chairman, UA Department of Surgery 

Professor of Surgery 

Specialties: 

Liver, Pancreas, and Bile Duct Cancer; 

Esophageal and Stomach Cancer; 

Endocrine Cancer – Thyroid, Parathyroid, Adrenal 

Hugo Villar, MD, specializes in the diagnosis and surgical treatment 

of cancers and tumors of the liver, pancreas, esophagus, stomach, 

and endocrine glands. As chief of the Division of Surgical Oncology 

and vice chairman of the Department of Surgery, he helps to promote 

the discovery of new 



Email: hvillar@surgery.arizona.edu 

research knowledge with a 

multidisciplinary approach 

to patient care. 

Dr. Villar is renowned 

for his leadership role as chairman of the Commission on Cancer 

for the American College of Surgeons and for his development and 

implementation of a Cancer Management Course throughout Latin 

America. Honored with numerous outstanding teaching awards, he 

also received the Patient’s Choice Award for Outstanding Skills and 

was voted one of the Best Doctors in America. He was named the 

Distinguished Latin American Surgeon in the United States for 2007 

by the Federation of Latin American Surgeons. 

Dr. Villar’s research interests include surgical oncology, 

intraoperative radiation therapy, and esophageal, pancreas, rectal, and 

breast cancer. He has published more than 100 journal articles and 

book chapters. 

Alfred Cohen, MD, FACS, FASCRS 

Surgical Director, Arizona Cancer Center 

Clinical Professor of Surgery, Division of Surgical 

Oncology 

Specialties: Colon, Rectal, and Anal Cancer 

Alfred Cohen, MD, a nationally known colorectal 

cancer surgeon, came to the UA from the Lucille P. Markey Cancer 

Center at the University of Kentucky, where he served as director and 

chief executive officer. Previously, he directed the colorectal cancer 

program at the Memorial Sloan-Kettering Cancer Center in New York 

City for 15 years. Before 



Cell Phone: (520) 400-0116 

Email: acohen@surgery.arizona.edu 

that, he was on the faculty 

at Harvard Medical School 

and Massachusetts General 

Hospital. 

Dr. Cohen is best known 

for his pioneering work in enhancing the quality of life for patients 

with rectal cancer. He perfected surgical techniques to minimize the 

need for colostomy bags; to preserve nerves and thus help prevent 

postoperative sexual and urinary problems; and to improve internal 

pouches and bowel function. 

Dr. Cohen is the author of 300 published articles and a major 

textbook in the field, was president of the Society of Surgical 

Oncology, and chaired the Commission on Cancer for the American 

College of Surgeons. 

– 6 – – 7 – 

Carlos Galvani, MD, FACS 

Director, Section of Minimally Invasive and 

Robotic Surgery 

Associate Professor of Surgery 

Specialties: Minimally Invasive and Robotic 

Approaches to Liver, Pancreas, and Bile Duct 

Cancer; Esophageal and Stomach Cancer 

Carlos Galvani, MD, came to the UA from the University of Illinois at 

Chicago (UIC), where he served as assistant professor and director of 

its renowned robotic and minimally invasive surgery program. 

Dr. Galvani is an internationally recognized expert in robotassisted 

surgery and other minimally invasive surgical techniques. 

He was a member of the UIC team that performed the world’s first 

robotic pancreatectomy (removal of the pancreas). He has extensive 

experience in bariatric surgery, single-incision laparoscopic surgery 

(SILS), robotic surgery of the gastrointestinal tract, robotic surgery 

for patients with gastroparesis, and laparoscopic solid-organ surgery. 

In addition, he performs robotic surgery for patients with benign and 



Email: cgalvani@surgery.arizona.edu 

malignant diseases of the 

esophagus, robotic living 

donor nephrectomies, and 

robotic liver resections. 

His research interests 

include clinical outcomes after laparoscopic and robotic surgery for 

patients with esophageal diseases, for living related kidney donors, and 

for bariatric patients. His studies have demonstrated that the use of 

robotics is highly beneficial for patients. 

Dr. Galvani has coauthored several chapters in surgical textbooks 

and more than 90 published articles and abstracts. 

Marlon Guerrero, MD 

Director, Endocrine Surgery Center 

Assistant Professor of Surgery, Division of Surgical 

Oncology 

Specialties: Endocrine Cancer – Thyroid, 

Parathyroid, Adrenal 

Marlon Guerrero, MD, directs the University of Arizona’s Endocrine 

Surgery Center, a multidisciplinary program specializing in treating 

patients with benign and malignant diseases of the thyroid gland, 

parathyroid glands, adrenal glands, and neuroendocrine pancreas.

The Endocrine Surgery Center offers open, laparoscopic, and 

minimally invasive surgery. It is a resource for patients in need of 

complex endocrine operations, including reoperative neck and 

abdomen procedures. 



Email: mguerrero@surgery.arizona.edu 

Dr. Guerrero has expertise 

in initial and redo lymph 

node dissections of the 

neck, ultrasound and 

dye-guided reoperations 

for thyroid cancer, minimally invasive and robotic thyroidectomies, 

minimally invasive parathyroidectomies, robotic and single-incision 

adrenalectomies, and open and laparoscopic pancreas resections. 

Dr. Guerrero’s research interests include thyroid carcinogenesis, 

advanced thyroid cancer, adrenocortical carcinoma, and the 

systemic effects of the hypercalcemia associated with primary 

hyperparathyroidism. He has published more than 20 articles in 

peer-reviewed journals. 

Craig Hurst, MD, MSc, FRCSC 

Chief, Division of Reconstructive Surgery 

Assistant Professor of Surgery 

Specialties: Reconstruction for 

Breast Cancer; Skin and Soft Tissue Cancer – 

Melanoma, Carcinoma, Sarcoma 

Craig Hurst, MD, provides reconstructive services to patients with 

breast or soft tissue cancer, ablative deficits, and complex wounds. 

Since his arrival at the UA in 2008, he has already treated hundreds of 

patients. 

The Breast Cancer Program provides comprehensive, 

multidisciplinary care for patients wishing either immediate (at the 

time of mastectomy) or delayed reconstruction. Dr. Hurst employs 

transverse rectus abdominal muscle (TRAM) flaps, latissimus flaps, 

tissue expanders, fat grafts, and acellular dermal matrices to create 

natural-appearing breasts 

with minimal downtime. 



Email: churst@surgery.arizona.edu 

The Skin Cancer 

and Sarcoma Program 

provides comprehensive, 

multidisciplinary care for patients with soft tissue tumors. Dr. Hurst 

has specialty training in reconstructive surgery of the head and neck 

region, including use of local and distant tissue transfers along with 

microsurgical reconstruction. 

Dr. Hurst’s research focus is on tissue engineering, 

tissue regeneration, and cryopreservation. He has published numerous 

articles and has been invited to speak on reconstructive topics both 

within the United States and internationally. 

Tun Jie, MD, MS, FACS 

Assistant Professor of Surgery, Division of 

Abdominal Transplantation 

Specialties: Liver, Pancreas, and Bile Duct Cancer 

Tun Jie, MD, MS, specializes in diseases affecting 

the liver, pancreas, bile ducts, and gallbladder. He 

performs complex surgical resections for patients with hepatocellular 

carcinoma, benign or malignant liver tumors and cysts, pancreatic 

cancer, neuroendocrine tumors of the pancreas, intraductal papillary 



Email: tjie@surgery.arizona.edu 

mucinous neoplasms of 

the pancreas, chronic 

pancreatitis, bile duct 

tumors, bile duct strictures, 

and gallbladder cancer. 

Dr. Jie’s research interests include liver transplants (for patients with 

liver or bile duct cancer) and total pancreatectomies with autoislet 

transplants (for patients with chronic pancreatitis). 

Julie Lang, MD 

Director, Breast Surgical Oncology 

Assistant Professor of Surgery, Division of 

Surgical Oncology 

Specialty: Breast Cancer 

Julie Lang, MD, a breast surgical oncologist, joined 

the UA after completing a Breast Surgical Oncology Fellowship at the 

nationally renowned MD Anderson Cancer Center in Houston. Her 

breast surgery practice focuses on the full spectrum of malignant and 

benign breast diseases, including breast masses, breast pain, abnormal 

mammograms, and breast cancer. She also consults with high-risk 

patients, such as those with a family history of breast cancer or with 

atypical breast biopsy findings. 



Email: jlang@azcc.arizona.edu 

Specializing in skin-sparing mastectomy and immediate 

reconstruction, Dr. Lang employs surgical techniques that optimize 

results both medically and cosmetically. She performs ultrasoundguided 

minimally invasive 

core needle biopsies of 

suspicious breast lesions, 

as well as sentinel lymph 

node biopsies (a minimally 

invasive technique to determine whether or not cancer has spread to 

lymph nodes). 

Dr. Lang’s research, relevant to all stages of breast cancer, focuses 

on circulating tumor cells and on breast cancer stem cells. The goal 

is to cure patients by treating even minimal residual disease. She has 

already coauthored several publications. 

– 8 – – 9 –

Evan Ong, MD, MS 


Oncology 

Specialties: Liver, Pancreas, and Bile Duct 

Cancer (including intraperitoneal hyperthermic 

chemoperfusion); Esophageal and Stomach Cancer; 

Skin and Soft Tissue Cancer (including isolated limb 

perfusion for melanoma, abdominal metastatic disease) 

Evan Ong, MD, focuses on gastrointestinal, pancreas, and liver 

cancer, with a particular interest in treatment options for patients with 

regional and metastatic disease. Fellowship-trained at the Roswell Park 



Email: eong@surgery.arizona.edu 

ablation to destroy primary or metastatic liver tumors. 

Cancer Institute in Buffalo, 

New York, he offers the 

latest technology, such as 

laparoscopic microwave 

and bipolar radiofrequency 

Dr. Ong has developed a program that uses intraperitoneal 

hyperthermic chemoperfusion (IPHC, sometimes abbreviated HIPEC), 

a procedure in which a warmed solution containing anti-cancer 

drugs is infused and circulated in the abdominal cavity for a short 

period. IPHC is a treatment option for patients with disseminated 

intraperitoneal disease (typically involving small metastatic nodules). 

A member of the Society of Surgical Oncology, Dr. Ong has more 

than 20 publications to his credit, including 2 book chapters. His 

research interests include the effect of immune modulation and 

aging on the development and progression of gastrointestinal cancer. 

Through his joint appointment with the Arizona Center on Aging, 

Dr. Ong is developing a geriatric assessment scoring system to better 

predict surgical outcomes in older patients. 

V. Liana Tsikitis, MD 

Director, Colorectal Surgery 


Oncology 

Specialties: Colon, Rectal, and Anal Cancer 

V. Liana Tsikitis, MD, fellowship-trained at the 

Mayo School of Graduate Medical Education in Rochester, Minnesota, 

is an expert in the complete array of open and minimally invasive 

procedures for diseases of the colon and rectum, including of the 

pelvic floor. She also has extensive experience with inflammatory 

bowel disease and benign anorectal problems. 

Her clinical areas of interest include colon and rectal cancer, as well 

as inflammatory bowel 



Email: ltsikitis@surgery.arizona.edu 

disease. Her practice also 

includes benign colorectal 

conditions that might 

require surgical treatment, 

such as diverticulitis, colonic polyps not amenable to removal by 

colonoscopy, perianal fistulas, fissures, and hemorrhoids. Dr. Tsikitis 

performs, in addition to surgical procedures, colonoscopies and 

anorectal ultrasound examinations. She provides a comprehensive, 

multidisciplinary approach for patients with pelvic floor disorders. 

Her primary research interests are the emerging field of colon and 

rectal cancer genetics and optimization of surveillance protocols for 

colon and rectal cancer patients. 

Amy Waer, MD, FACS 

Assistant Professor of Clinical Surgery, Division of 

Surgical Oncology 

Specialty: Breast Cancer 

Amy Waer, MD, is a member of the breast surgery 

team. She specializes in breast cancer and benign 

breast disease. 



Email: awaer@surgery.arizona.edu 

She is currently participating 

in a grant-funded 

study of the effect of Limonene, 

a lime citrus extract, 

in preventing and reducing breast cancer. In addition, she is participating 

in a research study of how couples cope with the diagnosis of 

breast cancer. 

James Warneke, MD, FACS 


Specialties: Skin and Soft Tissue Cancer – 

Melanoma, Carcinoma, Sarcoma 

James Warneke, MD, joined the UA faculty in 

1991. From 1992 to 2002, he served as the medical 

student clerkship director; from 2001 to 2009, as the residency 

director. 

Dr. Warneke’s clinical and research interests involve the treatment 

of patients with skin malignancies, especially melanoma and sarcoma. 

He treats patients with skin malignancies as part of a multidisciplinary 



Email: jwarneke@surgery.arizona.edu 

team effort that includes 

colleagues in dermatology, 

medical oncology, and 

dermatopathology. 

Similarly, for sarcoma 

patients, the multidisciplinary team includes colleagues in radiation 

oncology, medical oncology, and orthopedic oncology. 

Dr. Warneke is a co-principal investigator in a study, funded 

by a program project grant from the National Cancer Institute, of 

chemoprevention of skin cancer. He is the institutional surgical 

coordinator for the Arizona Cancer Center in the Southwest Oncology 

Group, a multicenter cooperative group funded by the National 

Cancer Institute to develop new cancer treatment mechanisms. 

– 10 – – 11 –

DIVISION OF Cardiothoracic Surgery 

Jonathan Daniel, MD, FACS 

Assistant Professor, Division of Cardiothoracic 

Surgery 

Specialties: Lung and Esophageal Cancer; Tumors 

of the Chest Wall and Mediastinum 

Jonathan Daniel, MD, a thoracic surgeon 

specializing in benign and malignant diseases of the lung and 

esophagus, came to the UA from Brigham and Women’s Hospital and 

Harvard Medical School, where he completed a dedicated thoracic 

surgery residency. 

His clinical interests embrace multidisciplinary approaches to 

thoracic malignancies affecting the lungs, esophagus, thymus, chest 

wall, and pleura (including mesothelioma). Dr. Daniel uses minimally 

invasive techniques for patients undergoing lung resection and for 

those with reflux disease, achalasia, and emphysema. In addition, he is 

a member of the lung transplantation program. 

Dr. Daniel’s research interests include nanotechnology applications 

for the treatment of lung cancer patients. He is a member of the 



Email: jdaniel@surgery.arizona.edu 

American Association 

for Cancer Research, 

the American College 

of Surgeons, and the 

American College of Chest 

Physicians. He is certified by the American Board of Surgery and 

the American Board of Thoracic Surgery. He has coauthored several 

published journal articles. 

DIVISION OF Urology 

Mitchell Sokoloff, MD, FACS 

Chief, Division of Urology 


Director, Urologic Surgical Oncology Program 

Codirector, Prostate Cancer Program, Arizona 

Cancer Center 

Director, Outpatient Surgery Clinics, University 

Medical Center 

Specialties: Prostate, Kidney, Testicular, Adrenal, and Penile Cancer 

Mitchell Sokoloff, MD, is a nationally recognized authority in the 

treatment of patients with prostate, kidney, testicular, adrenal, and 

penile cancer. One of only 2 urologists in Arizona with fellowship 

training in oncology, he was an early adopter of robotic surgery for 



Email: sokoloff@email.arizona.edu 

prostate cancer patients. An 

expert in both the diagnosis 

and treatment of prostate 

cancer, Dr. Sokoloff has 

been instrumental in 

developing rational approaches with regard to the role and technique 

of prostate biopsies, as well as innovative potency-preserving (nervesparing) 

and minimally invasive (laparoscopic and robotic) operations. 

He has also been a leader in embracing the role of active surveillance 

for men with early prostate cancer and multimodality therapies for 

men with more aggressive disease. 

In addition, Dr. Sokoloff is an authority on the management of 

kidney cancer, with particular expertise in complex partial (nephronsparing) 

nephrectomy and in the removal of large tumors (including 

those that involve surrounding organs and the inferior vena cava). 

He is among a limited number of surgeons in the United States with 

extensive experience in retroperitoneal lymph node dissections for 

men with testicular cancer. 

A research interest of his is combining novel and innovative drug 

therapies with conventional surgery to improve the outcomes for 

patients with aggressive and high-risk, locally advanced, or metastatic 

tumors. Working closely with clinicians and researchers at the Arizona 

Cancer Center, he is involved in a number of clinical trials focused 

on improving the diagnosis and management of prostate and kidney 

cancer. 

Dr. Sokoloff has long been recognized as an outstanding patient 

advocate and counselor; he has received multiple commendations and 

awards for patient care. A member of many professional organizations 

and societies, he has published numerous articles and book chapters 

– 12 – – 13 –

and has received awards for his research. He is a core member of 

several national cancer groups devoted to creating and evaluating new 

treatments for urologic cancer patients. 

Matthew Gretzer, MD, FACS 

Director, Genitourinary Reconstructive Surgery 

Assistant Professor of Surgery, Division of Urology 

Specialties: Prostate and Bladder Cancer 

Matthew Gretzer, MD, is the director of Genitourinary 

Reconstruction in the Division of Urology. 

He completed both a residency and advanced training in urologic 

reconstruction and surgical robotics at the Johns Hopkins Brady 

Urologic Institute. He specializes in the surgical treatment of 

prostate cancer patients, such as open and robotic nerve-sparing 

prostatectomies; he also has expertise in the management of urethral 

stricture disease. He 



Email: mgretzer@surgery.arizona.edu 

is one of only a few 

Arizona urologists who 

routinely perform complex 

urethroplasties. 

In addition, Dr. Gretzer specializes in the surgical management 

of male incontinence and in complex urinary diversion and 

reconstruction after prostate and bladder cancer surgery. He is 

involved in prostate cancer research and clinical trials investigating 

new surgical therapies for post-prostatectomy incontinence. 

Mike Nguyen, MD, FACS 

Director, Minimally Invasive Urologic Surgery 


Specialties: Prostate, Kidney, Testicular, and 

Adrenal Cancer 

Mike Nguyen, MD, completed a fellowship 

in minimally invasive urologic surgery at the Cleveland Clinic 

Foundation in Cleveland, Ohio. Using the latest laparoscopic and 

robotic approaches, he specializes in the evaluation and treatment of 

kidney cancer patients. His 

New Patient Referrals: (520) 694-4032 multipronged approach 

Private Office: (520) 626-6236 encompasses active 

Email: mnguyen@surgery.arizona.edu surveillance, cryoablation, 

and laparoscopic or robotic 

nephron-sparing partial nephrectomies and radical nephrectomies. 

In addition, he treats patients with benign kidney conditions, 

such as ureteral strictures and kidney obstruction (using minimally 

invasive techniques) and kidney stones (using endoscopic surgery, 

percutaneous surgery, and medical treatment). He also treats patients 

with bladder cancer (using robotic cystectomies with neobladder 

reconstruction) and prostate cancer (using robotic prostatectomy). 

Dr. Nguyen conducts clinical research in several areas – outcomes 

research, patient education and counseling, kidney cancer, and stone 

disease – and is widely published. 

Jonathan Walker, MD, FACS 


Specialties: Prostate, Bladder, Kidney, Testicular, 

Adrenal, and Penile Cancer 

Jonathan Walker, MD, completed a fellowship 

in urologic oncology at the National Institutes of 

Health’s National Cancer Institute in Bethesda, Maryland. His clinical 

expertise includes prostate, bladder, kidney, testicular, adrenal, and 



Email: walkerj1@email.arizona.edu 

penile cancer; he is skilled 

in open, laparoscopic, and 

robotic surgical techniques. 

A member of the Arizona 

Cancer Center, he is 

interested in research on the genetic analysis of prostate cancer and of 

renal cell carcinoma. 

– 14 – – 15 –

DIVISION OF Neurosurgery 

G. Michael Lemole, Jr., MD, FACS 

Chief, Division of Neurosurgery 


Specialty: Brain and Skull-Base Cancer 

G. Michael Lemole, Jr., MD, an authority on skull 

base surgery, previously headed the 

Skull Base Multidisciplinary Program at the University of Illinois 

at Chicago (UIC). He also codirected the Chicago CyberKnife 

Radiosurgery Center at Advocate Christ Medical Center. 

As the chief of neurosurgery at the UA Department of Surgery 

and University Medical Center, Dr. Lemole collaborates with 

multidisciplinary teams of surgeons and specialists to offer the full 

range of leading-edge surgical, radiosurgical, and medical treatments 

for patients with brain and spine disorders. 

Dr. Lemole’s clinical interests include diseases of the cranial base, 

or skull base, where all of the critical blood vessels and nerves enter 



Email: mlemole@surgery.arizona.edu 

or exit the skull. Skullbase 

diseases include 

both malignant and 

benign tumors, as well as 

congenital and traumatic 

anatomic defects. He also treats the wider variety of benign and 

malignant cranial neoplasms. 

Dr. Lemole has generated more than 30 peer-reviewed publications 

and 18 book chapters. He is currently researching the role of novel 

tumor markers in brain cancer. He is a member of several medical 

societies, including the American Association of Neurological 

Surgeons, the Congress of Neurological Surgeons, and the North 

American Skull Base Society. 

DIVISION OF Otolaryngology 

(Head and Neck Surgery) 

Alexander Chiu, MD, FACS 

Chief, Division of Otolaryngology 


Specialty: Sinonasal and Skull-Base Cancer 

Alexander Chiu, MD, has established an 

international reputation in sinonasal cancer, anterior 

skull-base surgery, and chronic rhinosinusitis. He specializes in 

endoscopic and minimally invasive techniques to remove benign and 

malignant tumors of the nose, paranasal sinuses, and anterior skull 

base. 

Along with Dr. Lemole, Dr. Chiu has established the Center for 

Management of Sinonasal and Skull-Base Tumors, which is staffed by 



a multidisciplinary team 

of surgeons, radiation 

oncologists, and medical 

oncologists. This team 

specializes in leading-edge, minimally invasive treatments for patients 

with benign and malignant sinonasal disease. 

Dr. Chiu is the co-editor-in-chief of the American Journal of 

Rhinology and Allergy and serves on the editorial board of ORL: Journal 

of Otorhinolaryngology. He is writing 2 textbooks on the management 

of sinonasal cancer and on surgical techniques for sinus and skull-base 

surgery. He has published more than 70 peer-reviewed articles and 

book chapters. 

– 16 – – 17 –

Practice Locations 

Arizona Cancer Center 

at UMC Orange Grove 

Arizona Cancer Center 

at UMC North 

HOSPITALS 

University Medical Center (UMC) 

1501 N. Campbell Ave. 

Tucson, AZ 85724 

University Physicians Healthcare (UPH) Hospital 

2800 E. Ajo Way 


University Medical 

Center (UMC) 

Multispecialty Surgery 

Clinic, UMC Fourth Floor 

and Fifth Floor 

University Physicians 

Healthcare (UPH) 

Hospital 

UPH Clinic 

East 

CLINICS 

Arizona Cancer Center at UMC North 



Phone: (520) 694-2873 

Fax: (520) 694-0255 

Multispecialty Surgery Clinic, 

UMC Fourth Floor 



Phone: (520) 694-1000 

Fax: (520) 694-5509 

Multispecialty Surgery Clinic, 

UMC Fifth Floor 



Phone: (520) 694-1000 

Fax: (520) 694-6101 

Arizona Cancer Center at UMC Orange Grove 

1891 W. Orange Grove Road 


Phone: (520) 742-4183 

Fax: (520) 742-4110 

UPH Clinic East 

Urology 

5240 E. Knight Dr., Suite 109 


Phone: (520) 694-4032 

Fax: (520) 694-5509 

– 18 – 

– 19 –

For more 

information, visit 

www.surgery.arizona.edu 

or call (520) 694-1000 

All contents © 2010 Arizona Board of Regents. All rights reserved. 

The University of Arizona is an equal opportunity, affirmative action institution. 

The University prohibits discrimination in its programs and activities on the basis of race, color, religion, 

sex, national origin, age, disability, veteran status, or sexual orientation and is committed to 

maintaining an environment free from sexual harassment and retaliation. 

August 2010

Cancer Surgery Physician Referral Guide - Department of Surgery

Create successful ePaper yourself

Delete template?

Save as template?